Trelegy ellipta 100-62.5-25 60S
Ended Awarded
- Contract number
- SPE2DB25FYFL8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,778
Award facts
- Contract value 100% obligated
- $48,778.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $48.78K firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) on September 5, 2025, with completion scheduled for September 8, 2025. This is a non-set-aside competitive award with performance based in Conshohocken, Pennsylvania. The delivery order represents a child action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99M global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp provides essential medications and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Trelegy Ellipta product—a combination respiratory medication used in chronic obstructive pulmonary disease treatment—exemplifies the company's role in delivering specialty brand-name pharmaceuticals across multiple therapeutic domains. This award demonstrates AmerisourceBergen's ongoing capability to meet federal procurement requirements through open competition and reflects DLA's reliance on established prime vendors for rapid fulfillment of military healthcare pharmaceutical needs.
Quick answers
Who was awarded contract SPE2DB25FYFL8?
SPE2DB25FYFL8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FYFL8 worth?
The government has obligated $48,778 on SPE2DB25FYFL8.
Is contract SPE2DB25FYFL8 an order under another contract?
Yes. SPE2DB25FYFL8 is a delivery order under SPE2DB24D1104, an indefinite delivery contract.
Was contract SPE2DB25FYFL8 competed?
The extent of competition for SPE2DB25FYFL8 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award